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Stem cell factor induces phosphatidylinositol 39-kinase–dependent Lyn/Tec/Dok-1
complex formation in hematopoietic cells
Thamar B. van Dijk, Emile van den Akker, Martine Parren-van Amelsvoort, Hiroyuki Mano, Bob Lo¨wenberg, and Marieke von Lindern
Stem cell factor (SCF) has an important
role in the proliferation, differentiation,
survival, and migration of hematopoietic
cells. SCF exerts its effects by binding to
cKit, a receptor with intrinsic tyrosine
kinase activity. Activation of phosphatidyl-
inositol 3*-kinase (PI3-K) by cKit was pre-
viously shown to contribute to many SCF-
induced cellular responses. Therefore,
PI3-K-dependent signaling pathways acti-
vated by SCF were investigated. The PI3-
K-dependent activation and phosphoryla-
tion of the tyrosine kinase Tec and the
adapter molecule p62Dok-1 are reported.
The study shows that Tec and Dok-1 form
a stable complex with Lyn and 2 unidenti-
fied phosphoproteins of 56 and 140 kd.
Both the Tec homology and the SH2 do-
main of Tec were identified as being re-
quired for the interaction with Dok-1,
whereas 2 domains in Dok-1 appeared to
mediate the association with Tec. In addi-
tion, Tec and Lyn were shown to phos-
phorylate Dok-1, whereas phosphory-
lated Dok-1 was demonstrated to bind to
the SH2 domains of several signaling
molecules activated by SCF, including
Abl, CrkL, SHIP, and PLCg-1, but not
those of Vav and Shc. These findings
suggest that p62Dok-1 may function as
an important scaffold molecule in cKit-
mediated signaling. (Blood. 2000;96:
3406-3413)
© 2000 by The American Society of Hematology
Introduction
Stem cell factor (SCF; also called steel factor, mast cell growth
factor, or Kit ligand) is an important growth factor for multiple cell
types, including hematopoietic progenitor cells. SCF exerts its
effects by binding to the product of the cKit proto-oncogene.1 cKit
is a receptor with intrinsic tyrosine kinase activity, structurally
related to Flt3 and the receptors for colony-stimulating factor-1 and
platelet-derived growth factor.2 Loss-of-function mutations in the
loci for murine cKit, White Spotting (W), or SCF, Steel,3-6 lead to
macrocytic anemia and to mast cell deficiency, as well as to a series
of nonhematological defects.1,7,8 Conversely, mutations that render
cKit constitutively active have been found in mastocytoma and
myeloproliferative disease.9,10
Within the hematopoietic compartment, SCF can support the
survival and renewal of the earliest multilineage progenitors and
regulates proliferation and differentiation of mast cell precursors.
In combination with lineage-restricted cytokines, SCF delays
differentiation and enhances the expansion of already committed
progenitors of all lineages.1 This phenomenon is particularly
apparent in erythropoiesis in which the cooperation of cKit with the
erythropoietin receptor (EpoR) is crucial for the proliferation of
erythroblasts.11,12 It has been shown that cKit and EpoR are closely
associated in erythroid cells,13 but the molecular basis for the
synergy between cKit and EpoR or other cytokine receptors has not
been resolved.
The profound effects of SCF on proliferation and survival of
different progenitor cell types has raised considerable interest in the
identification of critical signal transduction pathways activated by
cKit. SCF binding to cKit results in dimerization/oligomerization
and subsequent transient tyrosine phosphorylation of the receptor.14
As a result, proteins of the p21Ras-MAPK pathway, the phosphati-
dylinositol 39-kinase (PI3-K), the tyrosine kinases Src/Fyn/Lyn and
Tec, phospholipase Cg-1 (PLCg-1), Vav, Cbl, and p62Dok-1 are
recruited to the cKit-signaling complex and are subsequently
activated or phosphorylated.15-22 However, the mechanism by
which these molecules are recruited and activated has remained
largely unresolved. Although human and murine cKit contain 20
intracellular tyrosine residues, only a few were described as
docking sites for signaling molecules when phosphorylated. Ty-
rosines 703 and 936 in human cKit bind the adapter molecules
Grb2 and Grb7, whereas Src kinases bind to tyrosines 567 and 569
in the membrane proximal region, and p85 binds to tyrosine 719 in
the kinase-insert domain of murine cKit.16,23,24 A concerted action
of Src kinases and PI3-K appears to be required for the (indirect)
activation of the small G-protein Rac and the protein kinase JNK,
which is an important step in mast cell proliferation.24
In vitro studies have shown that activation of PI3-K contributes
to survival, mitogenesis, chemokinesis, and differentiation induced
by SCF.16,24-26 Introduction of cKit mutants unable to activate
PI3-K into cKit-deficient mast cells does not restore SCF-induced
cell adhesion and only partially restores SCF-induced prolifera-
tion.16 Furthermore, we recently observed that the PI3-K inhibitor
LY294002 suppressed the biological effect of SCF on erythroid
progenitors (manuscript in preparation). PI3-K yields PIP3 in the
cell membrane, thereby creating binding sites for pleckstrin
homology (PH) domain containing signaling molecules.27 The
tyrosine kinase Tec is one such PH domain that contains protein
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activated by cKit.18 Tec is also the founding member of a family of
tyrosine kinases that includes Bruton tyrosine kinase (BTK), Bmx,
Itk/Tsk/Emt, and Rlk/Txk.28,29 These kinases are characterized by a
PH and a Tec homology (TH) domain in their amino-terminus,
followed by SH3, SH2, and kinase domains.30 In contrast to Src
kinases, they are devoid of a membrane-targeting myristylation
site, and yet they are rapidly recruited to the plasma membrane
after stimulation of various cytokine receptors, the T- and B-cell
receptors, and CD28.31-35 The interaction between PIP3 and the PH
domain of BTK is critical for this translocation.36 In the plasma
membrane, Tec members are thought to be activated by Lyn or
other members of the Src family.37,38 Other studies have shown
that the TH domain of Tec is not only essential for the (in)direct
interaction with cKit but also for its association with Lyn
and Vav.33,39
In this study, we show that Tec is activated by SCF in erythroid
and megakaryocytic cell lines and that, when activated, it forms a
stable complex with various proteins, including the recently cloned
docking protein p62Dok-1. We found that both the activation of Tec
and the phosphorylation of Dok-1 require PI3-K activity. We show
that the TH and SH2 domains of Tec mediate the interaction with
Dok-1, whereas 2 separate domains in Dok-1 are involved in the
interaction with Tec. We further show that Tec, and also Lyn, can
phosphorylate Dok-1. Dok-1 contains 15 tyrosine residues, suggest-
ing an important role for Dok-1 in recruiting SH2 domain-
containing proteins to the cKit-signaling complex. In support of
this hypothesis, we provide evidence that phosphorylated Dok-1
binds the SH2 domains of multiple signaling molecules.
Materials and methods
Cells, plasmids, and oligonucleotides
The human erythroleukemia cell lines F36P and TF-1 as well as the
megakaryocytic cell line Mo7e were maintained in RPMI 1640 medium
(Life Technologies, Breda, The Netherlands) supplemented with 10% fetal
calf serum (FCS; Life Technologies) and recombinant human granulocyte-
macrophage colony-stimulating factor (GM-CSF; 5 ng/mL; Immunex;
Seattle, WA). COS, 293, and amphotropic Phoenix cells were cultured in
Dulbecco modified Eagle medium (DMEM; Life Technologies) supple-
mented with 10% FCS.
The complete complementary DNAs (cDNAs) of murine Tec, human
cKit, and human Dok-1 (a kind gift of N. Carpino, St Jude Children’s
Hospital, Memphis, TN) were cloned in the expression vector pSG5
(Stratagene, La Jolla, CA) and the retroviral vector pBabe.40 The expression
vectors encoding Tec mutants and Dp85 have been described previ-
ously.41,42 Constructs DokDY1 and DokDY5 were generated by polymerase
chain reaction (PCR) with the use of the oligonucleotides Dok-F (59-
CGGAATTCCCGGGGGCCATGGACGGA-39), Dok-DY1 (59-AAAACT-
GCAGGTTAACGGCTCTACAAGGAGTTCTCCAGC-39), and Dok-DY5
(59-AAAACTGCAGGTTAACCAGCCTACAGGGCTGGGGGACTG-39)
and the Expand High Fidelity PCR System (Roche; Basel, Switzerland).
Fragments were cloned in the EcoRI/PstI sites of a modified pSG5.
Constructs tagged with the hemagglutinin (HA) epitope, HA-Dok, HA-
DokDY5, and HA-DokDY1, respectively, were generated by subcloning
PCR products into pMT2SM-HA vector. The PstI fragment of pMT2HA-
Dok was subcloned into pBABE to generate pBHA-Dok.
Transient transfection and viral transduction
For transfection experiments, COS cells were cultured in 6-well dishes
(Costar; Corning, NY), and 293 cells were cultured in 20-cm2 dishes
(Becton Dickinson, Franklin Lakes, NJ). After 24 hours, the cells were
transfected with 6 to 12 mg of supercoiled plasmid DNA as described
previously.43 Sixteen to 20 hours after transfection, medium was refreshed,
and cells were harvested 24 hours later.
For viral transduction experiments, amphotropic Phoenix cells were
cultured in 6-well dishes and, 3 hours later, the cells were transfected with
the use of calcium phosphate. After 48 hours, cells were treated with
mitomycin C (10 mg/mL) for 1 hour, washed 3 times, and washed 3 more
times 4 hours later. F36P cells (2 3 105/mL) were added and co-cultured for
20 to 24 hours in RPMI/DMEM medium (50%/50%). F36P cells were
removed carefully from the Phoenix cells and cultured in RPMI 1640
medium. To select for stable transfected cells, puromycin (2 mg/mL) was
added 48 hours later.
Immunoprecipitations, Western blotting, and antibodies
After serum starvation for 16 hours, F36P, Mo7e, and TF-1 cells (30 3 106/
mL) were stimulated with SCF (100 ng/mL; a generous gift of Amgen,
Thousand Oaks, CA), EPO (5 U/mL; a generous gift of Janssen-Cilag,
Tilburg, The Netherlands), or GM-CSF (50 ng/mL), or left unstimulated for
5 minutes (SCF) or 10 minutes (EPO and GM-CSF) at 37°C. Reactions
were stopped by adding ice-cold phosphate-buffered saline (PBS). Cells
were lysed in lysis buffer (1% NP-40, 20 mmol/L Tris-HCl, pH 8.0, 137
mmol/L NaCl, 10 mmol/L EDTA, and 10% glycerol), supplemented with
Complete protease inhibitor mix [Roche], Pefablock [Merck, Darmstadt,
Germany], and 1 mmol/L orthovanadate) on ice for 15 minutes and
centrifuged at 4°C for 10 minutes at 15 000 rpm. Lysates of 15 3 106 cells
were precleared with protein G beads (Sigma; St Louis, MO), incubated
with the appropriate antibody (1 mg) for 90 minutes at 4°C, and protein G
beads were added for an additional hour. Precipitates were washed 3 times
with lysis buffer, subjected to SDS-polyacrylamide gel electrophoresis, and
electrotransferred to nitrocellulose membrane (Schleicher & Schuell;
Dassel, Germany). Membranes were blocked in 0.6% bovine serum
albumin (BSA), incubated with appropriate antibodies, and developed with
the use of enhanced chemoluminescence (ECL; NEN, Boston, MA).
The following antibodies were used in this study: anti-Tec (06-561;
Upstate Biotechnology, Lake Placid, NY), anti-TecSH3,31 anti-Dok-1
(M19; Santa Cruz, Santa Cruz, CA), antiphosphotyrosine (PY99; Santa
Cruz), anti-HA (F-7; Santa Cruz), anti-Lyn (Transduction Laboratories,
Lexington, KY), antiphospho-PKB (Ser473; New England BioLabs, Bev-
erly, MA), anti-PKB (New England BioLabs), antiphospho-ERK1,2 (Thr202/
Tyr204; E10; New England BioLabs), and anti-ERK1,2 (K-23; Santa Cruz).
Glutathione S-transferase (GST)-pull down experiments
For SH2 domain-inducing studies, SCF-stimulated Mo7e cells were lysed
in immunoprecipitation buffer. Cleared lysates were incubated for 90
minutes with beads coupled to 10 mg of GST-SH2 fusion protein or to GST
alone. Beads were washed 3 times with lysis buffer and resuspended in
sample buffer. Proteins were separated by SDS-PAGE and blotted with
antiphosphotyrosine antibody. The GST fusions with SH2 domains of the
following proteins were used in this study: cAbl, CrkL, Fgr, Fps, GAP (both
N- and C-terminal SH2 domains [N1C]), Grb14, Hck, Lyn, p85 subunit of
PI3-K (SH2 N1C), PLCg-1 (SH2 N1C), Shc, SHIP, Src, Syk (SH2 N1C),
Vav, and Yes.
Results
Tec is activated in erythroid cells and complexes
with various proteins after SCF addition
Tec has previously been shown to be activated by SCF in the
human megakaryocytic cell line Mo7e.18 To investigate whether
Tec is specifically activated on cKit activation and to identify
associating proteins, Tec was immunoprecipitated from the human
erythroid progenitor cell line F36P and was stimulated with SCF,
EPO, or GM-CSF, from Mo7e cells stimulated with SCF or
GM-CSF, and from human erythroleukemic TF-1 cells stimulated
with SCF. Subsequently, Tec and coprecipitating proteins were
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immunoblotted with antiphosphotyrosine antibody (PY99). As
shown in Figure 1A, phosphorylation of Tec in F36P cells is only
detected after SCF stimulation but not after incubation of the cells
with EPO or GM-CSF, even though these cytokines induced
tyrosine phosphorylation of multiple proteins (Figure 1A, lower
panel). An in vitro kinase assay confirmed that the tyrosine
phosphorylation of Tec correlated with enhanced kinase activity of
Tec (not shown). Interestingly, a prominent phosphorylated protein
of 62 kd as well as proteins of 145 to 150, 140, and 56 kd were
precipitated with Tec after SCF induction. The proteins of 145 to
150 kd were identified as cKit by Western blot analysis (not
shown). Because p56Lyn is known to associate with Tec,39 we
tested whether the coprecipitating phosphoprotein of 56 kd was
Lyn. Although the lower panel indeed shows that SCF treatment
results in enhanced Tec-Lyn association, Lyn had a slightly faster
mobility than p56. Therefore, the identities of p56 and p140
remain unknown.
Tec is also selectively phosphorylated by SCF in Mo7e cells
(Figure 1B). In these cells, a similar pattern of coprecipitating
proteins is observed, indicating that the same signaling complex is
formed after cKit activation in F36P and Mo7e cells. Although less
clear, cKit and p62 (marked with an asterisk) were also detected in
the Tec precipitates of SCF-stimulated TF-1 cells. The signal in
these cells is less intensive, most likely due to the lower level of
activated cKit when compared with F36P and Mo7e, as is apparent
from the whole cell lysate controls.
The p62 coprecipitating with Tec is p62Dok-1
The most prominent tyrosine phosphorylated protein in Tec precipi-
tates is a protein of 62 kd. Recently, Dok-1, a docking protein of 62
kd, was cloned from chronic myelogenous leukemia progenitor
cells and from v-Abl-transformed B cells.22,44 In these cells, Dok-1
is constitutively phosphorylated. To examine whether Tec-
associated p62 is identical to Dok-1, both Tec and Dok-1 were
precipitated from SCF-stimulated F36P cells, blotted, and incu-
bated with PY99. Figure 2A shows that p62 exactly comigrates
with the slower migrating species of Dok-1. Strikingly, proteins of
140 and 56 kd coprecipitate with Dok-1, similar to what is observed
when Tec is immunoprecipitated. These results suggest that
(partially) identical complexes are precipitated with anti-Tec and
anti-Dok sera. Reprobing of the blot with anti-Tec serum showed
that Tec was present in the Tec immunoprecipitations (Figure 2A,
lower panel). However, Tec was never detected in Dok-1 precipita-
tions, possibly due to sterical hindrance of the antibody. Therefore,
we assume that the coprecipitating p56 and p140 associate with
Dok-1 rather than with Tec.
The anti-Dok-1 antibody could not be used in Western blot
analysis but worked well in immunoprecipitations. To demonstrate
that p62 is indeed Dok-1, lysates of SCF-stimulated F36P cells
were first cleared with anti-Dok-1, followed by a Tec precipitation,
and vice versa. If Tec and Dok-1 associate, the signal of p62/Dok-1
should be decreased in Tec- and Dok-1-precleared precipitates. In
fact, significantly less p62 coprecipitates with Tec in lysates
precleared from Dok-1 (Figure 2B, lanes 4 and 5), whereas there is
almost no p62Dok remaining in a Dok-1 precipitate after the lysate
was precleared with anti-Tec (Figure 2B, lanes 7 and 8). Together,
these data are consistent with the notion that the Tec-interacting
protein of 62 kd is identical to Dok-1.
Tec and Dok phosphorylation depends on PI3-K activity
Like Tec, Dok-1 also contains a PH domain at its N-terminus,
suggesting that recruitment of both proteins to the cKit-signaling
Figure 2. The p62 coprecipitating with Tec is p62Dok-1. (A) Tec and Dok-1 were
immunoprecipitated from whole cell lysates of nonstimulated and SCF-incubated
F36P cells and analyzed by Western blotting with antiphosphotyrosine (PY99; top
panel) and anti-Tec (lower panel). Two species of Dok-1 are phosphorylated by SCF
(indicated by arrows), of which the upper one comigrates with Tec-associated p62.
Proteins of 56 and 140 kd are observed in both Tec and Dok-1 precipitates of
SCF-treated cells (indicated by arrows). (B) Lysates of SCF-stimulated F36P cells
were precleared with anti-Dok-1, followed by Tec immunoprecipitation, or vice versa.
The lysates were analyzed by Western blotting with antiphosphotyrosine (top panel)
and anti-Tec (lower panel). Pretreatment of the lysates reduces the amount of
phosphorylated p62/Dok-1, indicating that p62 is identical to the slower migrating
species of Dok-1.
Figure 1. Tec is activated in erythroid cells and complexes with various
proteins following SCF addition. (A, B) Tec was immunoprecipitated from F36P,
Mo7e, and TF-1 cells incubated with SCF (S; 5 minutes), EPO, or GM-CSF (E, GM;
10 minutes) at 37°C. The immunoprecipitates (15 3 106 cells each) were analyzed by
Western blotting with antiphosphotyrosine (PY99; top panels) and anti-Tec (middle
panels). Tec precipitates from F36P cells were also analyzed with anti-Lyn (middle
panel). As a control, whole cell lysates were analyzed with antiphosphotyrosine
(lower panels). Tec is specifically phosphorylated by SCF and complexes with cKit
and proteins of 56, 62, and 140 kd, following SCF addition (indicated by arrows).
Co-precipitating p62 in SCF-stimulated TF-1 cells is marked with an asterisk.
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complex could depend on PI3-K activation. To inhibit PI3-K
activity, both the fungal metabolite wortmannin (WM) and the
synthetic inhibitor LY294002 (LY) were employed. Pretreatment of
the cells with 20 nmol/L WM (20 minutes) or 15 mmol/L LY (60
minutes) was sufficient to almost completely block the SCF-
induced phosphorylation of Tec and the coprecipitating Dok-1
(Figure 3A-B). As controls, phosphorylation of the classical PI3-K
target, protein kinase B (PKB), and ERK were assessed. At 15
mmol/L LY, phosphorylation of PKB was completely blocked as
determined with specific antibodies against phospho-PKB (Ser473;
Figure 3B) and phospho-PKB (Thr308; not shown). In contrast,
this concentration of LY had no effect on the SCF-induced
activation of ERK1/2 (lower panel). These results demonstrate the
specificity of the PI3-K inhibitors and suggest that PI3-K activation
has to precede Tec/Dok phosphorylation, most likely to recruit
these proteins to the signaling complex. In addition, because
ERK1/2 phosphorylation is not affected by LY, it appears that
SCF-induced activation of the Ras-MAP kinase pathway is indepen-
dent of Dok-1 phosphorylation.
In addition to pharmacological inhibitors, a dominant negative
PI3-K construct (Dp85) was used to determine the role of PI3-K in
the phosphorylation of Tec and Dok-1. Tec, Dok-1, and Dp85 were
transiently coexpressed in various combinations in 293 cells.
Figure 3C shows that both Tec and Dok-1 are heavily phosphory-
lated on tyrosine residues when coexpressed. Interestingly, the
phosphorylation of both Tec and coprecipitated Dok-1 is reduced
when Dp85 is also transfected (lanes 1 and 2). Furthermore,
immunoprecipitation of Dok-1 shows that the phosphorylation of
Dok can also be blocked by cotransfection of Dp85 (lanes 4 and 5).
This finding indicates that PI3-K activity is required for the
phosphorylation of Tec and Dok-1 in 293 cells.
Dok-1 is a substrate of Tec and Lyn in 293 cells
To study the interaction of Tec and Dok-1, transient transfection
experiments were performed in 293 cells as well as in COS cells.
As shown in Figure 4A, immunoprecipitation of Tec from trans-
fected cells results in the detection of a single phosphorylated
protein, corresponding to Tec (lane 2). When Dok-1 is coexpressed
(lane 3), a 62 kd phosphoprotein is coprecipitated, indicating that
Tec and Dok-1 can form a complex in an overexpression system.
However, relatively little phosphorylated Dok-1 is precipitated
with Tec in this system when compared with F36P and Mo7e cells.
Notably, coexpression of Dok-1 reproducibly enhanced the phos-
photyrosine content of Tec (compare lanes 2 and 3), suggesting that
Figure 4. Dok-1 is a substrate of Tec and Lyn in 293 cells. (A) The 293 cells were
transfected with expression vectors encoding Tec, Lyn, or Dok-1, or with empty vector
(2). Tec immunoprecipitates were analyzed by Western blotting with antiphosphoty-
rosine (top panel) and anti-Tec (lower panel). Dok-1 coprecipitates with Tec,
especially in the presence of Lyn. (B) The 293 cells were cotransfected with
HA-tagged Dok-1 and Tec, together with (1) or without (2) Lyn. Lysates were
incubated with anti-HA, anti-Dok-1, or anti-Tec, after which the precipitates were
analyzed with anti-HA. Lyn stabilizes the interaction between Tec and HA-Dok-1. (C)
F36P cells were stably transfected with HA-Dok-1. Tec was precipitated from lysates
of nonstimulated (2) or SCF-treated (1) cells, after which the precipitates were
analyzed with antiphosphotyrosine (upper panel), anti-HA (middle panel), and
anti-Tec (lower panel). More HA-tagged Dok-1 is precipitated after SCF stimulation,
indicating that the association of Tec and Dok-1 is stabilized within the cKit-signaling
complex. (D) COS cells (upper panel) and 293 cells (lower panel) were transfected
with empty vector (2) or a Dok-1 expression plasmid (1), or cotransfected with Tec
and/or Lyn. Dok-1 immunoprecipitates were analyzed by Western blotting with
antiphosphotyrosine (top panel). In COS cells, both Tec and Lyn can phosphorylate
Dok-1, whereas in 293 cells Dok-1 is a better substrate for Tec than for Lyn.
Figure 3. Tec and Dok phosphorylation depends on PI3-K activity. F36P cells
were incubated with different concentrations of the PI3-K inhibitors wortmannin (WM;
20 minutes; A) or LY294002 (LY; 60 minutes; B) at 37°C, after which the cells were
incubated with SCF for 5 minutes. (A) Tec immunoprecipitates were analyzed by
Western blotting with antiphosphotyrosine (top panel) and anti-Tec (lower panel). WM
clearly inhibits Tec and Dok-1 phosphorylation. (B) Lysates were incubated with
anti-Tec and anti-Dok-1. Tec immunoprecipitates were analyzed by Western blotting
with antiphosphotyrosine and anti-Tec; Dok precipitates were analyzed with antiphos-
photyrosine. LY clearly inhibits Tec and Dok-1 phosphorylation. Whole cell lysates
(1 3 106 cells) were also analyzed with antiphospho-PKB and antiphospho-ERK as
control for the specificity of LY. LY inhibits PKB phosphorylation but not ERK
phosphorylation. (C) The 293 cells were transfected with expression vectors
encoding Tec, Dok-1, or Dp85, or with empty vector (2). Tec and Dok-1 immunopre-
cipitates were analyzed by Western blotting with antiphosphotyrosine (top panels)
and anti-Tec (lower left panel). Tyrosine phosphorylation of Tec and Dok-1 can be
blocked by coexpression of dominant negative PI3-K (Dp85).
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Dok-1 enhances the auto- or cross-phosphorylation of Tec, or
recruits an endogenous kinase that can phosphorylate Tec. The
tyrosine kinase Lyn has been shown to phosphorylate Tec,37 and it
was detected in a complex of Tec and Dok-1 in F36P cells (Figure
1A). Therefore, Lyn was coexpressed with Tec and Dok-1 in 293
cells. Lyn increased Tec phosphorylation (Figure 4A, compare
lanes 2 and 4) and enhanced the intensity of Dok-1 detected by
antiphosphotyrosine antibodies in a Tec immunoprecipitation (com-
pare lanes 3 and 5). The latter may be due to Lyn-induced increased
Dok-1 phosphorylation and/or increased stability of the Tec/Dok-1
complex. To examine an effect of Lyn on the Tec/Dok-1 interac-
tion, Tec was coexpressed with a Dok-1 tagged at the N-terminus
with the HA epitope, which allowed detection of total Dok-1 on
Western blots. More HA-Dok was coprecipitated with Tec when
Lyn was cotransfected (Figure 4B, lanes 3 and 4), suggesting that
Lyn stabilizes the Tec/Dok-1 interaction. To analyze whether the
association of Tec and Dok-1 is similarly enhanced through
SCF-signaling, Tec was immunoprecipitated from F36P cells
stably transfected with HA-Dok. Activation of cKit indeed in-
creased the association of Dok-1 and Tec (Figure 4C). These data
suggest that Lyn plays an important role in SCF-induced Tec/Dok-1
complex formation, which could be due to phosphorylation of
Dok-1 that allows interaction of the Tec SH2 domain with the
phoshotyrosines of Dok-1.
To examine whether Lyn is able to phosphorylate Dok-1
directly, Lyn and Tec were coexpressed with Dok-1 in COS and 293
cells. In COS cells, both Tec and Lyn induced massive Dok-1
phosphorylation, whereas they had an additive effect when cotrans-
fected (Figure 4D, upper panel). Under these conditions, both Tec
and Lyn coprecipitated with Dok-1 (indicated with arrows). In 293
cells, the SV40-driven promoter on the pSG5 plasmid is less active,
resulting in a more modest expression of Tec and Lyn. In these
cells, Dok-1 is a better substrate for Tec than for Lyn (Figure 4D,
lower panel, lanes 3 and 4). Moreover, Lyn had no additive effect
on Tec-mediated Dok phosphorylation (lane 5). Thus, although Lyn
can phosphorylate Dok-1, its tyrosine phosphorylation appears to
depend mainly on Tec activity.
In conclusion, activation of cKit stabilizes the interaction
between Tec and Dok-1, possibly by Lyn-mediated Dok-1 phosphor-
ylation. Subsequently, Tec phosphorylates Dok-1 to yield highly
tyrosine-phosphorylated Dok-1.
Domains involved in Tec/Dok association
Given the interaction observed between Tec and Dok-1, we next
examined which domains were involved. Wild-type (wt) Tec and
Tec deletion constructs (see Figure 5B for a schematic representa-
tion) were coexpressed with HA-Dok-1 in 293 cells. Subsequently,
Tec precipitates were blotted and probed with anti-HA- and
antiphosphotyrosine antibodies. Wt Tec, TecDSH3, and TecDKD
bind equal amounts of HA-Dok-1 (Figure 5A, upper panel). In
contrast, TecDPH is much more powerful in HA-Dok-1 binding,
whereas no HA-Dok-1 is precipitated with TecDTH and TecDSH2.
Similar results are obtained when the blot is probed with PY99, ie,
an equal Dok-1 phosphorylation by wt Tec and TecDSH3, en-
hanced phosphorylation with TecDPH, and no phosphorylation
with TecDTH, TecDSH2. The only difference concerned TecDKD
(no kinase activity), which failed in Dok-1 phosphorylation even
though it precipitated HA-Dok-1, showing that indeed Tec kinase
activity is responsible for the phosphorylation of HA-Dok-1. The
detection of high levels of phosphorylated Dok-1 by TecDPH is
most likely due to enhanced Dok-1 binding (upper panel). Expres-
sion of Tec constructs was controlled with an antibody against the
TH domain, therefore, TecDTH could not be detected (Figure 5A).
Staining the blot with an antibody against the SH3 domain of Tec
showed that TecDTH was expressed comparable to wt Tec (not
shown). These data show that 2 independent domains of Tec, the
TH domain and the SH2 domain, interact with Dok-1.
Dok-1 is a docking protein that contains a PH domain, a
phosphotyrosine-binding (PTB) domain, 15 tyrosine residues, and
10 proline (PXXP) motifs. The phosphorylated tyrosines can act as
SH2-binding sites, whereas the PXXP motifs mediate binding to
SH3 domains. To roughly map the region(s) of Dok-1 that associate
with Tec, 2 progressive deletion constructs were created (Figure
5C). In HA-DokDY5, 193 amino acids were deleted at the
C-terminus, which removes 10 tyrosine residues and 5 PXXP
motifs. HA-DokDY1 consists of only the PH domain, 1 tyrosine,
and 2 PXXP motifs. The HA-Dok constructs were cotransfected
with Tec in 293 cells. Lysates were incubated with anti-HA
antibody as control (Figure 5D, left panel) and with anti-Tec to
detect the Tec/Dok interaction (right panel). The interaction of Tec
with full-length Dok-1 is easily detected, whereas no HA-DokDY1
is observed in Tec precipitates. HA-DokDY5 also associates with
Tec, although at a low level, suggesting that 2 domains in Dok-1
cooperate in binding to Tec. Alternatively, multiple phosphoty-
rosines of Dok-1 are able to bind the SH2 domain of Tec.
SH2 domains of distinct signaling molecules bind
to phosphorylated Dok-1
We demonstrated that SCF induces the complex formation of
Dok-1 with Tec and Lyn and that Dok-1 is subsequently phosphor-
ylated on tyrosine residues. Phosphorylated tyrosines act as
binding sites for SH2-containing proteins. To determine which
signaling intermediates could bind to phosphorylated Dok-1, GST
fusion proteins that contained the SH2 domains from a range of
Figure 5. Domains involved in Tec/Dok association. (A) The 293 cells were
cotransfected with HA-Dok-1 and different Tec mutants. Tec immunoprecipitates
were analyzed by Western blotting with anti-HA (top panel), anti-Tec (middle panel),
and antiphosphotyrosine (lower panel). The TH and SH2 domains of Tec are crucial
for the direct interaction with HA-Dok-1. (B) Schematic representation of the Tec
mutants used and their Dok-1 interaction and phosphorylation properties. (C)
Schematic representation of full-length HA-Dok-1, HA-DokDY5, and HA-DokDY1.
Tyrosine residues (Y), the PH and PTB domains and total number of amino acids are
indicated. (D) The 293 cells were cotransfected with Tec and different HA-Dok-1
deletion constructs. Lysates were incubated with anti-HA for expression control and
with anti-Tec. Precipitates were analyzed with anti-HA. Although the HA-Dok deletion
constructs are equally expressed (left panel), only full-length HA-Dok and a reduced
amount of HA-DokDY5 are detected in Tec precipitates (right panel), indicating that 2
domains in Dok-1 are involved in the binding to Tec.
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signaling molecules were incubated with lysate from SCF-
stimulated Mo7e cells. The SH2 domains of the Src family
members Src, Fgr, Hck, and Yes; the tyrosine kinase cAbl; the
adapter CrkL; rasGAP (SH2 N1C); the p85 subunit of PI3-K (SH2
N1C); PLCg (SH2 N1C); and SHIP bind efficiently to phospho-
Dok-1 (Figure 6). However, the SH2 domains of Fps, Grb14, Shc,
Syk (SH2 N1C), and Vav show little or no association with Dok-1,
illustrating a high level of substrate specificity. Precipitates that
contain Dok-1 also include proteins of 145 to 150, 140, and 56 kd,
although with different ratios. It cannot be excluded that some of
the GST-SH2 fusion proteins directly bind to cKit and thereby
indirectly precipitate Dok-1. However, these results strongly sug-
gest that Dok-1 can recruit a variety of signaling proteins and,
therefore, that Dok-1 may play an important role in SCF-
mediated signaling.
Discussion
Various studies have shown that SCF-mediated proliferation,
survival, adhesion, migration, and differentiation depend on PI3-K
activity.16,24-26 PI3-K yields PIP3 in the cell membrane, which can
subsequently recruit PH domain-containing signaling molecules.27
One such protein activated by SCF is the tyrosine kinase Tec. We
found that activation of cKit induces both Tec activation and the
formation of a complex of Tec with cKit, Lyn, p62Dok-1, and 2
unidentified proteins of 56 and 140 kd, respectively. By using
pharmacological inhibitors and overexpression of Dp85, a domi-
nant negative PI3-K construct, we determined that both complex
formation and phosphorylation require PI3-K activity. The Dp85
transfection was done in a transient assay, because we failed to
generate cell lines that stably expressed Dp85 or cKitY721F, a cKit
mutant unable to activate PI3-K. We propose a model for Dok-1 in
SCF signaling as shown in Figure 7. This model involves the
activation of PI-3K and Src family members (eg, Lyn) following
cKit stimulation. The PH domain-containing proteins Tec and
Dok-1 are recruited to the plasma membrane where they colocalize
with activated Lyn. Lyn associates with Tec and promotes its kinase
activity. Subsequently, Tec and/or Lyn phosphorylate Dok-1,
creating binding sites for SH2-containing proteins. It is possible
that such Dok-1-interacting proteins are phosphorylated by Tec
and/or Lyn as well.
Tec and Dok-1 are partially associated in nonstimulated serum-
starved F36P and Mo7e cells (Figure 1), indicating that the
interaction is relatively stable in vivo. In cotransfection studies,
however, the Tec/Dok-1 association is rather weak, although Dok-1
is heavily phosphorylated by Tec when coexpressed (Figure 4A and
4D, respectively). With the use of an HA-tagged Dok-1 construct, it
was shown that cKit stimulation stabilizes the association between
Tec and Dok (Figure 4C). This implies that additional proteins are
necessary to allow the formation of a stable complex. Our results
suggest that Lyn is such a protein (Figure 4B). Furthermore, Lyn
also phosphorylates Dok-1 (Figure 4D), whereas the SH2 domain
of Tec is crucial for its association with Dok-1 (Figure 5A). One
possible mechanism to explain these results is that Lyn phosphory-
lates a subset of tyrosines in Dok-1, including the one(s) that
mediate(s) the interaction with Tec. In turn, Tec may phosphorylate
another subset of tyrosines of Dok-1. To further clarify the role of
Tec in the phosphorylation of Dok-1 in vivo, we tried to stably
transfect F36P cells with a Tec construct that lacked its kinase
domain. However, in all clones obtained the expression level of this
mutant was too low to act as a dominant negative. It can, therefore,
not be excluded that Src family members fully account for the
phosphorylation of Dok-1 in vivo. During our studies, Tec was
identified as a possible kinase for CD28-mediated Dok-1 phosphor-
ylation, whereas a Dok-related protein (Dok-R or p56Dok-2) has
been reported as a direct target of Lyn.35,45 These data are consistent
with the conclusion that Dok-1 and Dok-related proteins are
substrates for both the Tec and Src families of tyrosine kinases.
Dok-1 was first identified as a tyrosine-phosphorylated protein
of 62 kd associated with p120-RasGAP in fibroblasts transfected
with v-Src.46 In BCR-Abl-transformed cells, Dok-1 also binds to
RasGAP in a tyrosine phosphorylation-dependent manner. How-
ever, RasGAP was not detected in Tec and Dok-1 precipitates,
although RasGAP was detectable in RasGAP precipitates and in
whole cell lysate controls (data not shown). In contrast, we detected
a tyrosine-phosphorylated protein of 140 kd in Tec or Dok-1
precipitates of SCF-stimulated cells. Interestingly, a protein of
about the same size was shown to bind to Dok-R in epidermal
growth factor–stimulated cells.45 A protein that is activated by SCF
and has a molecular weight of 150 kd is the inositol phosphatase
SHIP-1. Therefore, we are currently investigating the role of this
protein in the Dok-1 complex. In addition, the identity of p56
remains to be defined. Both p56Lyn and p52Shc are known to bind
to Tec but have another electrophoretic mobility than Dok-bound
p56 (data not shown).
Still little is known about the physiological role of Dok-1.
Dok-1 is directly associated with v-Abl and constitutively phosphor-
ylated in chronic myelogenous leukemia cells.44,47 Furthermore, the
Figure 6. SH2 domains of distinct signaling molecules bind to phosphorylated
Dok-1. GST-fusion proteins containing the SH2 domains of several signaling
molecules were incubated with lysates of SCF-induced Mo7e cells. As a reference for
p62Dok-1, a Tec immunoprecipitate was included. The precipitates were analyzed by
Western blot analysis with an antiphosphotyrosine antibody (upper panels). The blots
were stained with Ponceau S as a control for the amount of added GST-fusion protein
(lower panels). Phosphorylated Dok-1 binds to the SH2 domains of various signaling
intermediates.
Figure 7. Model for Tec/Dok-1 phosphorylation in SCF-induced signaling. See
“Discussion” section for details.
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extent of tyrosine phosphorylation of Dok-1 has been shown to
correlate with the transforming capacities of a number of different
oncogenes, including v-Src, v-Fps, v-Fms, and v-Abl.46 Because of
the frequently noted correlation between constitutive tyrosine
phosphorylation of Dok-1 and cellular transformation, it has been
suggested that Dok-1 plays an important role in mitogenic signal-
ing. This idea is in agreement with the observations that Dok-1 is
phosphorylated in response to SCF and that SCF primarily serves
as a potent proliferation factor in hematopoietic progenitor cells.
The results of other studies have suggested that Dok-1 may also
play a role in cellular migration responses. Recently, Noguchi et
al48 showed that overexpression of wt Dok-1 enhanced insulin-
induced migration, but this was not observed with DokY361F, a
Dok-1 mutant unable to bind Nck. Nck is an adapter molecule that
links receptors to p21cdc42/Rac-activated kinase and the Wiskott-
Aldrich syndrome protein-interacting protein complex, all of which
contribute to changes in the actin cytoskeleton.49,50 Furthermore,
Rac has been shown to be activated by cKit via a Src- and
PI3-K-dependent mechanism and plays an important role in
SCF-induced proliferation of bone marrow-derived mast cells.24
One may speculate that the Tec/Dok-1 complex recruits and
activates the components that regulate the (de)polymerization of
actin filaments, thereby regulating cell migration.
Dok-1 contains a PTB domain, 15 tyrosine residues, and 10
PXXP motifs and has an overall structure related to the insulin-
receptor substrates 1 to 4 and GAB, all of which serve as docking
molecules.51 By recruiting subsets of signaling molecules into an
activated receptor complex, docking molecules play a key role in
the coordination of the cellular response. Others22,48 have shown
that p120RasGAP and Nck directly bind to Dok-1, whereas our
results indicate that Tec as well as at least 2 unidentified proteins
associate to Dok-1. We further showed that many SH2 domains of
proteins functioning in different signaling routes form a complex
with Dok-1. These include the SH2 domains of Abl, CrkL, PLCg-1,
SHIP as well as the p85 subunit of PI3-K, all proteins known to be
activated by SCF.16,19,21,52 Because CrkL is a direct target of
BCR-Abl,53 it is possible that Dok-1 plays a role in the recruitment
of kinases (Tec, Lyn, Abl) and their substrates. With the notion that
the pleiotropic effects of SCF largely depend on PI3-K, as is the
phosphorylation of Dok-1, we postulate that Dok-1 (and its
phosphorylation control) is an important regulator of SCF-induced
signal transduction.
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